Zobrazeno 1 - 10
of 501
pro vyhledávání: '"Vassilis Georgoulias"'
Autor:
Stefania Kokkali, Ioannis Boukovinas, Eelco de Bree, Anna Koumarianou, Vassilis Georgoulias, Anastasios Kyriazoglou, Nikolaos Tsoukalas, Nikolaos Memos, John Papanastassiou, Anastasia Stergioula, Konstantinos Tsapakidis, Konstantia Loga, Jose Duran-Moreno, Panagiotis Papanastasopoulos, Nikolaos Vassos, Vasileios Kontogeorgakos, Ilias Athanasiadis, Luiza Mahaira, Efthymios Dimitriadis, Dionysios J. Papachristou, George Agrogiannis
Publikováno v:
Cancers, Vol 16, Iss 13, p 2314 (2024)
Precise classification of sarcomas is crucial to optimal clinical management. In this prospective, multicenter, observational study within the Hellenic Group of Sarcoma and Rare Cancers (HGSRC), we assessed the effect of expert pathology review, coup
Externí odkaz:
https://doaj.org/article/1eb7d12ad7284ed69f2d28350b01fa4b
Autor:
Eleni D. Lagoudaki, Anastasios V. Koutsopoulos, Maria Sfakianaki, Chara Papadaki, Georgios C. Manikis, Alexandra Voutsina, Maria Trypaki, Eleftheria Tsakalaki, Georgia Fiolitaki, Dora Hatzidaki, Emmanuel Yiachnakis, Dimitra Koumaki, Dimitrios Mavroudis, Maria Tzardi, Efstathios N. Stathopoulos, Kostas Marias, Vassilis Georgoulias, John Souglakos
Publikováno v:
Cancers, Vol 16, Iss 10, p 1818 (2024)
To investigate the incidence and prognostically significant correlations and cooperations of LKB1 loss of expression in non-small cell lung cancer (NSCLC), surgical specimens from 188 metastatic and 60 non-metastatic operable stage I-IIIA NSCLC patie
Externí odkaz:
https://doaj.org/article/0a3e4dd4897144cb8743b8f5519a770b
Autor:
Argyro Roumeliotou, Areti Strati, Foteini Chamchougia, Anastasia Xagara, Victoria Tserpeli, Stavroula Smilkou, Elina Lagopodi, Athina Christopoulou, Emmanouil Kontopodis, Ioannis Drositis, Nikolaos Androulakis, Vassilis Georgoulias, Filippos Koinis, Athanasios Kotsakis, Evi Lianidou, Galatea Kallergi
Publikováno v:
Cells, Vol 13, Iss 9, p 782 (2024)
CXCR4, JUNB and PD-L1 are implicated in cancer progression and metastasis. The current study investigated these biomarkers in CTCs isolated from metastatic prostate cancer (mPCa) patients at the RNA and protein levels. CTCs were isolated from 48 mPCa
Externí odkaz:
https://doaj.org/article/294d3b8652e6404dada182c52483d9a6
Autor:
Dimitra Stergiopoulou, Athina Markou, Areti Strati, Martha Zavridou, Eleni Tzanikou, Sophia Mastoraki, Galatea Kallergi, Vassilis Georgoulias, Evi Lianidou
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Liquid biopsy (LB) provides a unique minimally invasive tool to follow-up cancer patients over time, to detect minimal residual disease (MRD), to study metastasis-biology and mechanisms of therapy-resistance. Molecular characterization of CT
Externí odkaz:
https://doaj.org/article/144fb851fcc643398e29bf3d322421cb
Autor:
Stefania Kokkali, Emmanouil Saloustros, Dimitra Stefanou, Paris Makrantonakis, Nikolaos Kentepozidis, Ioannis Boukovinas, Nikolaos Xenidis, Panagiotis Katsaounis, Alexandros Ardavanis, Nikolaos Ziras, Athina Christopoulou, George Rigas, Kostas Kalbakis, Nikolaos Vardakis, Christos Emmanouilides, Ilias Athanasiadis, Athanassios Anagnostopoulos, Dora Hatzidaki, Efthimios Prinarakis, Foteini Simopoulou, Athanasios Kotsakis, Vassilis Georgoulias
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 1237-1251 (2022)
Front-line bevacizumab (BEV) in combination with taxanes offers benefit in progression-free survival (PFS) in metastatic breast cancer (mBC). The medical records of mBC patients, treated with front-line BEV-based chemotherapy, were retrospectively re
Externí odkaz:
https://doaj.org/article/c982903354104203bb48bb3d0972f59f
Autor:
Filippos Koinis, Zafeiris Zafeiriou, Ippokratis Messaritakis, Panagiotis Katsaounis, Anna Koumarianou, Emmanouil Kontopodis, Evangelia Chantzara, Chrissovalantis Aidarinis, Alexandros Lazarou, George Christodoulopoulos, Christos Emmanouilides, Dora Hatzidaki, Galatea Kallergi, Vassilis Georgoulias, Athanasios Kotsakis
Publikováno v:
Cancers, Vol 15, Iss 18, p 4511 (2023)
Rational: Circulating tumor cells (CTCs) appear to be a promising tool for predicting the clinical outcome and monitoring the response to treatment in patients with solid tumors. The current study assessed the clinical relevance of monitoring CTCs in
Externí odkaz:
https://doaj.org/article/9d0191d5a4e04c91ba4064e8dc882ede
Autor:
Ioannis V. Kostopoulos, Nikolaos Orologas-Stavrou, Nikolaos Angelis, Ioannis S. Pateras, Athanasios Kotsakis, Vassilis Georgoulias, Constantin N. Baxevanis, Graham Pawelec, Ourania E. Tsitsilonis
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 26, Iss 11, Pp 1373-1382 (2021)
The 4th Summer School in Immuno-Oncology was held from July 1st–July 3rd as a web meeting. Many eminent researchers and leading oncologists from Europe and the USA working on basic, translational and clinical cancer research participated, presented
Externí odkaz:
https://doaj.org/article/04d39bb0c3944fe0977633a85edc5875
Autor:
Sofia Mastoraki, Ioanna Balgkouranidou, Emily Tsaroucha, Apostolos Klinakis, Vassilis Georgoulias, Evi Lianidou
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2412-2422 (2021)
MLL3 histone methyltransferase, encoded by the KMT2C gene, is a tumor suppressor that has an essential role in cell‐type‐specific gene expression. We evaluated the prognostic significance of KMT2C promoter methylation as a circulating epigenetic
Externí odkaz:
https://doaj.org/article/ac1d7c9c14a84789a0789d2ca92edcf4
Autor:
Vasileios Vardas, Julia A. Ju, Athina Christopoulou, Anastasia Xagara, Vassilis Georgoulias, Athanasios Kotsakis, Catherine Alix-Panabières, Stuart S. Martin, Galatea Kallergi
Publikováno v:
Cells, Vol 12, Iss 15, p 1940 (2023)
Metastasis, rather than the growth of the primary tumor, accounts for approximately 90% of breast cancer patient deaths. Microtentacles (McTNs) formation represents an important mechanism of metastasis. Triple-negative breast cancer (TNBC) is the mos
Externí odkaz:
https://doaj.org/article/3b5941a6f1cd4905b7f87e5dede30642
Autor:
Vasileios Vardas, Anastasios Tolios, Athina Christopoulou, Vassilis Georgoulias, Anastasia Xagara, Filippos Koinis, Athanasios Kotsakis, Galatea Kallergi
Publikováno v:
Cancers, Vol 15, Iss 7, p 1974 (2023)
Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype. There are few targeted therapies for these patients, leading to an unmet need for new biomarkers. The present study aimed to investigate the expression of PD-L1, CTLA-
Externí odkaz:
https://doaj.org/article/6bc918489e684fa197dbbabc6551f429